Clinical Trials Arena September 19, 2024
Abigail Beaney

As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing vaccine trials.

In August 2024, the World Health Organization (WHO) declared mpox a public health emergency of international concern (PHEIC), two years after the agency previously declared an emergency for an outbreak of the virus with the epicentre in Europe.

The organisation has called on companies and governments to rally together to help countries in Africa by providing vaccines where possible, however, due to there being just one approved vaccine available, there is an urgent need for more development.

Clinical research on mpox has been relatively neglected. As a result, there are several unmet needs in the treatment space.

A recent trial...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Healthcare System, Public Health / COVID, Trends
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial

Share This Article